Cancer Clinical Trials
Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for cancer. Corterve aggregates actively recruiting Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Cancer studies
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Goodyear, Arizona
- Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyNCT01834001National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701PHASE1PfizerFayetteville, Arkansas
- NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid TumorsNCT07489378National Cancer Institute (NCI)Bethesda, Maryland
- Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryNCT07686250PHASE2H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066PHASE2PfizerHuntsville, Alabama
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844PHASE3National Cancer Institute (NCI)Fayetteville, Arkansas
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967PHASE2National Cancer Institute (NCI)Orange, California
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNCT06287775PHASE1, PHASE2National Cancer Institute (NCI)Duarte, California
- Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast CancerNCT07652242PHASE1Immunomic Therapeutics, Inc.Grand Rapids, Michigan
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsNCT04657068PHASE1, PHASE2Artios Pharma LtdBirmingham, Alabama
- Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")NCT07411599PHASE1, PHASE2M.D. Anderson Cancer CenterHouston, Texas
Cancer trials by state
Cancer trials by metro
Frequently asked questions
- How do I find recruiting Cancer clinical trials?
- Corterve aggregates actively recruiting Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.